Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 5703 of 5804
-
Stroke device trial pulled before it even started
Disease control TerminatedThe device is indicated for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease
Phase: NA • Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc. • Aim: Disease control
Last updated Jun 26, 2026 12:55 UTC
-
Glucose monitor study for gestational diabetes withdrawn before starting
Knowledge-focused TerminatedThis is a nested multicenter prospective cohort conducted concurrently and in conjunction with the DECIDE two-arm, pragmatic non-inferiority comparative effectiveness Randomized Controlled Trial (RCT) (NCT06445946) of metformin versus insulin among individuals with Gestational di…
Sponsor: Ohio State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Bile duct device study pulled before it began
Disease control TerminatedThe goal of this clinical trial is to assess basic feasibility, safety, and performance of an EUS access device in patients with malignant biliary obstruction who are indicated to receive EUS-guided hepaticogastrostomy for biliary drainage. The main questions it aims to answer ar…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Nasal insulin brain study pulled before it even started
Knowledge-focused TerminatedThe purpose of this study is to find out whether insulin, a drug approved by the FDA for the treatment of diabetes mellitus, reaches the brain and spinal cord when delivered as a nasal spray (intranasally). Intranasal insulin has been shown to improve memory and mood in patients …
Phase: PHASE1 • Sponsor: HealthPartners Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
COPD study in egypt withdrawn before it began
Knowledge-focused TerminatedChronic obstructive pulmonary disease (COPD) is a common, progressive disease characterized by airflow obstruction which is not fully reversible. Acute exacerbations of COPD (AECOPD) are described as worsening of COPD symptoms (breathlessness, cough, and sputum volume and purulen…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Weight-Loss supplement study pulled before it started
Disease control TerminatedThis study aims to evaluate the effects of the combined formula WM Formula, used as a dietary supplement, with a focus on improvements in glycemic and lipid parameters, body composition, and gut microbiota profiles.
Phase: NA • Sponsor: TCI Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Nurse personality test could shape future hospital training
Knowledge-focused CompletedPersonality traits and leadership styles among nurses influence professional behaviour, communication, clinical decision-making, teamwork, and quality of patient care. Training needs assessment is essential to identify competency gaps and improve nursing performance. This study a…
Sponsor: Sri Ramachandra Institute of Higher Education and Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
New drug IBI3032 tested for safety in small human study
Knowledge-focused CompletedThis is a randomized, double-blind, placebo-controlled Phase I clinical study evaluating the safety, tolerability, PK and food effect of a single dose of IBI3032 in healthy participants. This is a single ascending dose (SAD) study. Approximately 40 healthy participants are expect…
Phase: EARLY_PHASE1 • Sponsor: Innovent Biologics Technology Limited (Shanghai R&D Center) • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
New drug BIIB142 tested in humans for the first time
Knowledge-focused Recruiting nowIn this study, researchers will learn more about the safety of BIIB142 and how it is processed in the body. This is the first time that researchers will learn about BIIB142 and how it affects people. The main question researchers want to answer in this study is: • How many part…
Phase: PHASE1 • Sponsor: Biogen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Neck treatment for concussion symptoms: small pilot study tests feasibility
Symptom relief TerminatedAssess the feasibility of recruiting, enrolling and randomizing patients with concussion symptoms and neck pain to receive manual therapy and cervical rehabilitative exercises in addition to standard concussion treatment. In the usual care workflow provided at the participating …
Phase: NA • Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
New poxvirus drug candidate tested in healthy people
Knowledge-focused Recruiting nowA Two-Phase, Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 for Injection Following Single or Multiple Doses in Healthy Subjects
Phase: PHASE1 • Sponsor: China National Biotec Group Company Limited • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Breathwork study for stressed nursing students ends early
Symptom relief TerminatedPurpose of the Study This study investigates whether Holotropic Breathwork (HB)-a technique involving controlled hyperventilation paired with music and guided support-can improve the mental, emotional, and existential well-being of nursing students. The researchers aim to: Eval…
Phase: NA • Sponsor: University of Nebraska • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Pfizer tracks experimental Drug's path in healthy men
Knowledge-focused CompletedThe purpose of this study is to learn how the body processes the study medicine PF-07104091. The study is seeking participants who are: \- Healthy male aged 18 to 65 years of age Participants in the study will receive 14C-labeled PF-07104091 by mouth after a meal. After 14 day…
Phase: PHASE1 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Healthy volunteers help test how food and acid pills affect new drug absorption
Knowledge-focused CompletedThis is a Phase 1, open-label, randomized, single-center study to evaluate the effect of food and a proton pump inhibitor (PPI) on the pharmacokinetics (PK) of VRN110755 in healthy adult participants. The primary aim of this study is to assess the impact of food and rabeprazole c…
Phase: PHASE1 • Sponsor: Voronoi, Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Pfizer tests drug interaction in 12 healthy volunteers
Knowledge-focused CompletedThe purpose of the study is to learn how the study medicine called fluconazole changes how the body processes the other study medicine called PF-07248144. The study will also look at the safety, tolerability, and how the medicine is changed and removed from the body after taking …
Phase: PHASE1 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
New drug RBD1119 put to the test in healthy volunteers
Knowledge-focused OngoingThis is a Randomized, Single-blind, Placebo-Controlled Phase I Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Doses of Subcutaneously Administered RBD1119 in Healthy Participants.
Phase: PHASE1 • Sponsor: Suzhou Ribo Life Science Co. Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Healthy men help test drug interaction in new study
Knowledge-focused CompletedThe main objective of this trial is to investigate the effect of bosentan, a moderate Cytochrome P450 (CYP) 3A inducer on the single dose pharmacokinetics of nerandomilast.
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Teprotumumab safety check in healthy chinese participants
Knowledge-focused CompletedThe primary objective of the study is to evaluate the pharmacokinetics (PK) of teprotumumab after a single intravenous (IV) infusion of teprotumumab in healthy Chinese participants.
Phase: PHASE1 • Sponsor: Amgen • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Healthy volunteers help compare two injection devices for amlitelimab
Knowledge-focused CompletedThis is a single-center, open-label, randomized, single-dose, parallel, Phase 1, 4-arm study designed to determine the bioequivalence and investigate the safety and tolerability profiles of subcutaneous amlitelimab delivered by 2 different devices at 2 different total doses in he…
Phase: PHASE1 • Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Healthy men swallow radioactive drug to reveal its journey through the body
Knowledge-focused CompletedTo Evaluate the Mass Balance Recovery, Metabolite Profile and Metabolite Identification in Healthy Male Subjects
Phase: PHASE1 • Sponsor: JW Pharmaceutical • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC